MedTrace Logo

Message Communicating Latest Data on COVID-19 Transmission in Patient's Area

NCT05621226 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 520000

Last updated 2023-03-03

No results posted yet for this study

Summary

This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination by communicating to patients that they live in an area with significant COVID transmission and a control message telling patients that an updated COVID booster vaccine is waiting for them.

Conditions

Interventions

BEHAVIORAL

COVID Booster text messages

Participants will receive text messages per descriptions listed in the arms.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-03
Primary Completion
2022-12-08
Completion
2023-02-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05621226 on ClinicalTrials.gov